Innospec stock has third-quarter results scheduled for November 3, 2026

Published on 10/15/2026 at 22:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 491.40 million, up 11.80 percent year over year. Innospec stock costs EUR 86.25 on October 15, 2026.

Upcoming results and valuation

Innospec will publish third-quarter 2026 results on November 3, 2026.
Second-quarter revenue reached USD 491.40 million, up 11.80 percent year over year.
Innospec stock costs EUR 86.25 at Lang & Schwarz on October 15, 2026 at 10:07 p.m. CEST.
Innospec carried a P/E ratio of 19.71 and a market capitalization of USD 2.4 billion on October 15, 2026.

IOSP, US45768S1050, Illustration mit AI erstellt.

Innospec stock has third-quarter results scheduled for November 3, 2026, according to the company's Investor Relations release dated October 5, 2026. Innospec was trading at EUR 86.25 at Lang & Schwarz on October 15, 2026 at 10:07 p.m. CEST.

Second-quarter revenue reached USD 491.40 million

The latest reported period gave investors a concrete operating benchmark. In its second-quarter results, Innospec generated USD 491.40 million in revenue and diluted earnings per share of USD 1.25, according to MarketBeat. Revenue was up 11.80 percent from USD 439.50 million in the year-earlier quarter, while earnings per share exceeded the USD 1.05 consensus estimate by USD 0.20.

Price position on October 15

The Nasdaq quote was USD 96.60 at 4:00 p.m. ET on October 15, 2026. The session range was USD 96.11 to USD 98.20, and trading volume reached 136,551 shares against an average volume of 190,428 shares.

The 52-week range stood at USD 65.51 to USD 100.48. The latest USD quote was 3.86 percent below the high and 47.46 percent above the low, placing the stock nearer the upper end of its annual range.

Valuation and the next reporting date

Innospec had a market capitalization of USD 2.4 billion and a P/E ratio of 19.71 on October 15, 2026. The scheduled November 3 release will cover the third quarter of 2026, followed by a conference call on November 4, 2026, at 9:00 a.m. ET, according to the October 5 Investor Relations release.

Comparison with peers

Innospec (NASDAQ, USD): P/E 19.71, market capitalization USD 2.4 billion
Eastman Chemical (NYSE, USD): plus 1.57 percent, P/E 16.59, market capitalization USD 7.3 billion
Albemarle (NYSE, USD): plus 0.23 percent, market capitalization USD 11.6 billion

What the next report can clarify

The November reporting date gives the stock a defined near-term calendar marker. The current valuation also sits alongside a second-quarter revenue increase of 11.80 percent, making the next release important for judging whether that growth rate carried into the third quarter.

The euro quote was trading at EUR 86.25 at Lang & Schwarz on October 15, 2026 at 10:07 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Innospec stock.